Rein Therapeutics Inc. (RNTX)
NASDAQ · Healthcare
Rein Therapeutics Inc. Revenue 2015–2025
Rein Therapeutics Inc. annual/quarterly revenue history and growth rate from 2015 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Rein Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 0.
- Rein Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 0.
- Rein Therapeutics Inc. annual revenue for 2025 was 0.
- Rein Therapeutics Inc. annual revenue for 2024 was 0.
- Rein Therapeutics Inc. annual revenue for 2023 was 0.
- Rein Therapeutics Inc. annual revenue for 2022 was 0.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
Rein Therapeutics Inc. (RNTX) — Frequently Asked Questions
Rein Therapeutics Inc. (RNTX) is a publicly traded US company. It has a market capitalization of $23M. Explore RNTX's stock price, financial statements, earnings history, margins and key ratios below.
What is Rein Therapeutics Inc.'s market cap?
Rein Therapeutics Inc. (RNTX) has a market capitalization of $23M.
What is the RNTX stock price?
RNTX trades at $0.92 (+0.04% on the day).
Is RNTX profitable?
In fiscal 2025, Rein Therapeutics Inc. reported net income of -$50M.